This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Peregrine Pharmaceuticals Inc (PPHM)

NASDAQ: Health Care

Company Balance Sheet
Apr 2014 Apr 2012 Apr 2011 Apr 2010
Cash and Equivalents 77.49M 18.03M 23.08M 19.68M
Receivables 1.33M 2.35M 1.48M 1.85M
Inventories 5.53M 3.61M 5.28M 3.12M
Other Current Assets 0.00 0.00 21.00K 122.00K
Total Current Assets 85.77M 24.79M 30.82M 26.78M
Property, Plant & Equipment, Gross 9.86M 8.64M 7.14M 5.84M
Accumulated Depreciation & Depletion 7.42M 5.74M 4.93M 4.37M
Property, Plant & Equipment, Net 2.45M 2.90M 2.21M 1.47M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 2.33M 570.00K 1.74M 1.09M
Total Non-Current Assets 4.77M 3.47M 3.95M 2.56M
Liabilities & Shareholder Equity
Total Assets 90.54M 28.26M 34.77M 29.34M
Accounts Payable 2.43M 3.49M 4.05M 2.26M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 502.00K 5.92M 2.95M 3.48M
Total Current Liabilities 22.21M 17.64M 17.68M 14.40M
Long Term Debt 0.00 0.00 0.00 1.32M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 639.00K 1.14M 1.67M 210.00K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 639.00K 1.14M 1.67M 1.52M
Total Liabilities 22.85M 18.78M 19.35M 15.93M
Preferred Stock Equity 1.00K 0.00 0.00 0.00
Common Stock Equity 67.70M 9.48M 15.42M 13.41M
Common Par 179.00K 101.00K 70.00K 53.00K
Additional Paid In Capital 470.78M 347.51M 311.35M 275.21M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -403.27M -338.12M -296.00M -261.85M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 67.70M 9.48M 15.42M 14.72M
Total Equity 67.70M 9.48M 15.42M 13.41M
Total Liabilities & Stock Equity 90.54M 28.26M 34.77M 29.34M
Total Common Shares Outstanding 178.87M 101.42M 69.84M 53.09M
Preferred Shares 775.00K 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 161.58M 83.57M 60.89M 49.07M
Diluted Weighted Shares Outstanding 161.58M 83.57M 60.89M 49.07M
Number of Employees 180 172 154 139
Number of Part-Time Employees 4 2 2 7

PPHM Peregrine Pharmaceuticals Inc

Analysts Ratings for PPHM

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

PPHM Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs